Genetic variants at the


Journal

RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038

Informations de publication

Date de publication:
12 2021
Historique:
received: 19 07 2021
accepted: 19 11 2021
entrez: 15 12 2021
pubmed: 16 12 2021
medline: 5 1 2022
Statut: ppublish

Résumé

Fatigue is common and severe in primary Sjögren's syndrome (pSS). The aim of this study was to identify genetic determinants of fatigue in pSS through a genome-wide association study. Patients with pSS from Norway, Sweden, UK and USA with fatigue and genotype data available were included. After genotype imputation and quality control, 682 patients and 4 966 157 genetic markers were available. Association analysis in each cohort using linear regression with fatigue as a continuous variable and meta-analyses between the cohorts were performed. Meta-analysis of the Norwegian and Swedish cohorts identified five polymorphisms within the same linkage disequilibrium block at the receptor transporter protein 4 ( Genetic variations at

Identifiants

pubmed: 34907023
pii: rmdopen-2021-001832
doi: 10.1136/rmdopen-2021-001832
pmc: PMC8671987
pii:
doi:

Substances chimiques

MASP1 protein, human EC 3.4.21.-
Mannose-Binding Protein-Associated Serine Proteases EC 3.4.21.-

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI082714
Pays : United States
Organisme : Medical Research Council
ID : MR/J002720/1
Pays : United Kingdom
Organisme : NIDCR NIH HHS
ID : U01 DE017593
Pays : United States
Organisme : Medical Research Council
ID : G0800629
Pays : United Kingdom
Organisme : NIDCR NIH HHS
ID : R01 DE018209
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR065953
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Rheumatology (Oxford). 2010 Jul;49(7):1294-302
pubmed: 20353956
J Neuroinflammation. 2013 Nov 23;10:139
pubmed: 24267924
Invest New Drugs. 2015 Jun;33(3):621-31
pubmed: 25822109
Nat Genet. 2009 Nov;41(11):1228-33
pubmed: 19838195
Front Immunol. 2019 Jul 19;10:1696
pubmed: 31379879
PLoS One. 2013 Dec 31;8(12):e83149
pubmed: 24391741
Neurosci Biobehav Rev. 1988 Summer;12(2):123-37
pubmed: 3050629
Nat Genet. 2010 Dec;42(12):1118-25
pubmed: 21102463
Arthritis Res Ther. 2015 Oct 05;17:254
pubmed: 26435495
J Crohns Colitis. 2015 Sep;9(9):725-30
pubmed: 25994356
Ann Rheum Dis. 2010 Jun;69(6):1103-9
pubmed: 19561361
J Rheumatol. 2004 Oct;31(10):1896-902
pubmed: 15468350
Innate Immun. 2016 Apr;22(3):162-7
pubmed: 26921255
Curr Opin Neurol. 2020 Jun;33(3):391-396
pubmed: 32304437
PLoS One. 2012;7(1):e30123
pubmed: 22253903
Nat Rev Neurosci. 2018 Mar;19(3):138-152
pubmed: 29416128
J Immunol. 2008 May 1;180(9):6132-8
pubmed: 18424734
Nat Genet. 2013 Oct;45(10):1238-1243
pubmed: 24013639
Nat Rev Genet. 2005 Apr;6(4):333-40
pubmed: 15803201
Trends Neurosci. 2014 Jan;37(1):39-46
pubmed: 24239063
Clin Exp Rheumatol. 2016 Jul-Aug;34(4 Suppl 98):21-4
pubmed: 27586799
Brain Behav Immun. 2009 Nov;23(8):1104-8
pubmed: 19560535
Curr Opin Neurol. 1996 Dec;9(6):456-60
pubmed: 9007405
Arthritis Care Res (Hoboken). 2014 Aug;66(8):1227-32
pubmed: 24339344
Brain Behav Immun. 2011 Oct;25(7):1376-83
pubmed: 21496483
Ann Rheum Dis. 2016 Nov;75(11):2029-2036
pubmed: 26857698
Nat Genet. 2014 Apr;46(4):409-15
pubmed: 24633160
Brain Behav Immun. 2017 May;62:230-244
pubmed: 28089639
Nat Genet. 2013 Nov;45(11):1284-92
pubmed: 24097067
SAGE Open Med. 2019 May 13;7:2050312119850390
pubmed: 31205695
Br J Dermatol. 2017 Aug;177(2):505-512
pubmed: 28182255
Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):16045-50
pubmed: 18836069
Ann Rheum Dis. 2015 May;74(5):859-66
pubmed: 24442883
Rheumatol Int. 2005 Aug;25(6):481-4
pubmed: 15071755
Rheumatology (Oxford). 2016 Jun;55(6):1074-82
pubmed: 26966136
Mol Neurobiol. 2015 Aug;52(1):318-29
pubmed: 25159480
PM R. 2010 May;2(5):456-65
pubmed: 20656628
Rheumatology (Oxford). 2011 Jun;50(6):1009-18
pubmed: 21285230
Mol Cell Biol. 2002 Dec;22(24):8506-13
pubmed: 12446770
J Stroke Cerebrovasc Dis. 2015 Mar;24(3):618-21
pubmed: 25542762
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Rheumatology (Oxford). 2019 Feb 15;:
pubmed: 30770713
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Arthritis Res Ther. 2011;13(5):R167
pubmed: 21996338
Scand J Immunol. 2018 May;87(5):e12662
pubmed: 29655283
Brain Behav Immun. 2012 Jul;26(5):699-705
pubmed: 22251605
Diabetes Care. 2011 Oct;34(10):e158
pubmed: 21949230
Clin Exp Rheumatol. 2017 Mar-Apr;35(2):255-261
pubmed: 28032845
PLoS One. 2012;7(6):e38668
pubmed: 22701688

Auteurs

Katrine Brække Norheim (KB)

Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway.
Department of Clinical Science, University of Bergen, Bergen, Norway.

Juliana Imgenberg-Kreuz (J)

Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway.
Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Andrei Alexsson (A)

Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Svein Joar Auglænd Johnsen (SJA)

Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway.

Kjetil Bårdsen (K)

Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway.

Johan Gorgas Brun (JG)

Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.

Rezvan Kiani Dehkordi (RK)

Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Elke Theander (E)

Department of Clinical Science, Lund University, Lund, Sweden.

Thomas Mandl (T)

Department of Clinical Science, Lund University, Lund, Sweden.

Roland Jonsson (R)

Department of Clinical Science, University of Bergen, Bergen, Norway.

Wan-Fai Ng (WF)

Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Christopher J Lessard (CJ)

Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.

Astrid Rasmussen (A)

Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.

Kathy Sivilis (K)

Translational Sciences, Rheumatology, Janssen Pharmaceutical Companies of Johnson and Johnson, New York, New York, USA.

Lars Ronnblom (L)

Rheumatology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Roald Omdal (R)

Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway roald.omdal@sus.no.
Department of Clinical Science, University of Bergen, Bergen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH